Literature DB >> 6091711

Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.

D K Sommers, M van Wyk, J Moncrieff, H S Schoeman.   

Abstract

The present study was designed to investigate the effect of food and of a raised intragastric pH on the bioavailability of two prodrug beta-lactam, antibiotics, namely bacampicillin and cefuroxime axetil. Six healthy volunteers participated in an intraindividual comparison of absorption of (a) prodrug, (b) breakfast, followed by prodrug, (c) breakfast, ranitidine and sodium bicarbonate followed by prodrug, and (d) ranitidine and sodium bicarbonate, followed by prodrug. All volunteers were dosed with both bacampicillin and cefuroxime axetil under the above regimens. The drug-free periods between trials were 7 days. Blood samples were obtained before and 20, 40, 60, 90, 120, 150, 180, 210 min and 4, 5, 6, 8 and 10 h after administration. The urine was collected for a period of 10 h after dosing with the antibiotic. An estimation of the relative bioavailability of the drugs under the various regimens was made by comparing the average areas under the serum concentration time curves and also the amounts recovered in the urine. Both food and reduced gastric acidity decreased the bioavailability of bacampicillin (as ampicillin) and these variables had an additive lowering effect on the AUC and percentage urinary recovery. Possibly this ester becomes partially hydrolyzed prior to absorption on raising the intragastric pH. Adsorption onto food components or complexing with proteins may also play a role in the reduced bioavailability of bacampicillin in the presence of food. In contrast, the absorption of the cefuroxime ester was enhanced postprandially. This may be rationalized in terms of delayed gastric emptying and gastrointestinal transit which allows more complete dissolution or prolonged residence at the most favourable site of absorption in the intestine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091711      PMCID: PMC1463630          DOI: 10.1111/j.1365-2125.1984.tb02501.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Gastrointestinal absorption and metabolism of two 35S-labelled ampicillin esters.

Authors:  A Swahn
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

Review 2.  Antacid therapy and drug kinetics.

Authors:  A Hurwitz
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 3.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

4.  Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects.

Authors:  P G Welling; H Huang; P A Koch; W A Craig; P O Madsen
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

5.  Antimicrobial activity and human pharmacology of amoxicillin.

Authors:  H C Neu
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

6.  Effect of food on nitrofurantoin absorption.

Authors:  T R Bates; J A Sequeira; A V Tembo
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

7.  Comparison of ampicillin and hetacillin pharmacokinetics in man.

Authors:  W J Jusko; G P Lewis
Journal:  J Pharm Sci       Date:  1973-01       Impact factor: 3.534

8.  Effect of cimetidine on oral absorption of ampicillin and cotrimoxazole.

Authors:  H J Rogers; C A James; P J Morrison; I D Bradbrook
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

  8 in total
  22 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].

Authors:  F Kees; K G Naber
Journal:  Infection       Date:  1990       Impact factor: 3.553

3.  Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.

Authors:  Hannah M Jones; Neil Parrott; Gerd Ohlenbusch; Thierry Lavé
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.

Authors:  N C James; K H Donn; J J Collins; I M Davis; T L Lloyd; R W Hart; J R Powell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 5.  Comparative pharmacokinetics of the new oral cephalosporins.

Authors:  H Lode; M Fassbender; T Schaberg; K Borner; P Koeppe
Journal:  Drugs       Date:  1994       Impact factor: 9.546

6.  Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs.

Authors:  P K Honig; B K Gillespie
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

7.  Pharmacokinetic study of lenampicillin (KBT-1585) in healthy volunteers.

Authors:  A Saito; M Nakashima
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

8.  Cefuroxime axetil for treatment of uncomplicated gonorrhea.

Authors:  A Gottlieb; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

9.  Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist.

Authors:  N Saathoff; H Lode; K Neider; K M Depperman; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

Review 10.  Cefetamet pivoxil clinical pharmacokinetics.

Authors:  R A Blouin; K Stoeckel
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.